Economic benefits of vaccination need to be seen in wider contextBMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d3721 (Published 14 June 2011) Cite this as: BMJ 2011;342:d3721
- Bob Roehr
- 1Washington, DC
Improvements in vaccines and their delivery could save the lives of an estimated 6.4 million children and prevent many disabilities over the next 10 years in the world’s 72 poorest countries, show new figures published in a Health Affairs focus issue on vaccines (http://content.healthaffairs.org/content/30/6.toc).
The cost of the vaccines is projected to be around $17bn (£10.4bn; €12bn) over 10 years, with additional funds needed to deliver them. But the savings in healthcare costs and greater economic productivity would far outweigh the costs, said Orin Levine, director of the International Vaccine Access Center of the Johns Hopkins Bloomberg School of Public Health, Baltimore.
“We need to move from a narrow view of the economic benefits of vaccination to a broader one,” he told a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial